Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Substance Abuse Treatment, Prevention, and Policy
Published in: Substance Abuse Treatment, Prevention, and Policy 1/2015

Open Access 01-12-2015 | Research

PrEP in substance abuse treatment: a qualitative study of treatment provider perspectives

Authors: Anya Y Spector, Robert H Remien, Susan Tross

Published in: Substance Abuse Treatment, Prevention, and Policy | Issue 1/2015

Login to get access

Abstract

Objectives

To examine substance abuse treatment providers’ views on engaging clients in Pre-exposure Prophylaxis (PrEP) care and research trials.

Methods

Thirty-six medical and counseling service providers in six New York City outpatient substance abuse treatment programs participated in semi-structured qualitative interviews. Thematic content analysis was conducted by three coders, independently.

Results

Providers’ perspectives toward PrEP were characterized by six salient themes: 1) Limited PrEP awareness. 2) Ambivalence about PrEP; 3) Perception of multiple challenges to delivery; 4) Uncertainty about clients’ ability to be adherent to medication; 5) Concerns about medication safety/side effects; and 6) Perception of multiple barriers to conducting clinical trials.

Conclusions

Despite anticipated challenges, providers supported the introduction of PrEP in outpatient substance abuse treatment. Comprehensive training for providers is needed and should include PrEP eligibility criteria, strategies to support adherence and medication monitoring guidelines. Linkages between substance abuse treatment and primary care and/or enhancement of capacity within clinics to offer PrEP may help facilitate PrEP delivery. When conducting research in outpatient clinics, it is particularly important to protect client confidentiality.
Literature
1.
Substance Abuse and Mental Health Services Administration, O. o., & Studies, A: Treatment Episode Data Set (TEDS): 1992–2000. National Admissions to Substance Abuse Treatment Services. In D. o. H. a. H. Services (Ed.). Rockville, MD: DASIS Series: S-17; 2002.
2.
3.
Kalichman SC, Cain D, Zweben A, Swain G: Sensation seeking, alcohol use and sexual risk behaviors among men receiving services at a clinic for sexually transmitted infections. J Stud Alcohol 2003, 64:564–9.PubMed
4.
Palepu A1, Raj A, Horton NJ, Tibbetts N, Meli S, Samet JH: Substance abuse treatment and risk behaviors among HIV-infected persons with alcohol problems. J Subst Abuse Treat 2005,28(1):3–9. 10.1016/j.jsat.2004.09.002PubMedCrossRef
5.
Ross MW, Hwang LY, Zack C, Bull L, Williams ML: Sexual risk behaviours and STIs in drug abuse treatment populations whose drug of choice is crack cocaine. Int J STD AIDS 2002,13(11):769–74. 10.1258/095646202320753736PubMedCrossRef
6.
Des Jarlais DC, Arasteh K, McKnight C, Hagan H, Perlman DC, Semaan S: Associations between herpes simplex virus type 2 and HCV with HIV among injecting drug users in New York City: the current importance of sexual transmission of HIV. Am J Public Health 2011,101(7):1277–83. 10.2105/AJPH.2011.300130PubMedCentralPubMedCrossRef
7.
Des Jarlais DC, Arasteh K, Perlis T, Hagan H, Abdul-Quader A, Heckathorn DD: Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City. Aids 2007,21(2):231–5. 10.1097/QAD.0b013e3280114a15PubMedCrossRef
8.
Hagan H, Perlman DC, Des Jarlais DC: Sexual risk and HIV infection among drug users in New York City: a pilot study. Subst Use Misuse 2011,46(2–3):201–7.PubMedCrossRef
9.
Mathers BM, Degenhardt L, Phillips B, Wiessing L, Hickman M, Strathdee SA: Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet 2008,372(9651):1733–45. 10.1016/S0140-6736(08)61311-2PubMedCrossRef
10.
Edlin BR, Irwin KL, Multicenter Crack Cocaine and HIV Infection Study Team: Intersecting epidemics–crack cocaine use and HIV infection among inner-city young adults. New Engl J Med 1994,331(21):1422–7. 10.1056/NEJM199411243312106PubMedCrossRef
11.
Colfax G: Substance use and sexual risk: a participant- and episode-level analysis among a cohort of men who have sex with men. Am J Epidemiol 2004,159(10):1002–12. 10.1093/aje/kwh135PubMedCrossRef
12.
Shoptaw S, Frosch D: Substance abuse treatment as HIV prevention for men who have sex with men. AIDS Behav 2000, 42:2.
13.
Shoptaw S, Reback CJ: Associations between methamphetamine use and HIV among men who have sex with men: A model for guiding public policy. J Urban Health 2006,83(6):1151–7. 10.1007/s11524-006-9119-5PubMedCentralPubMedCrossRef
14.
Wolitski RJ, Stall R, Valdiserri RO: Unequal opportunity: health disparities affecting gay and bisexual men in the United States. US: Oxford University Press; 2007.CrossRef
15.
Aicken CR, Nardone A, Mercer CH: Alcohol misuse, sexual risk behaviour and adverse sexual health outcomes: evidence from Britain’s national probability sexual behaviour surveys. J Public Health (Oxf) 2011,33(2):262–71. 10.1093/pubmed/fdq056CrossRef
16.
Castilla J, Barrio G, Belza MJ, de la Fuente L: Drug and alcohol consumption and sexual risk behaviour among young adults: results from a national survey. Drug Alcohol Depend 1999,56(1):47–53. 10.1016/S0376-8716(99)00008-3PubMedCrossRef
17.
Van Tieu H, Koblin BA: HIV, alcohol, and noninjection drug use. Curr Opin HIV AIDS 2009,4(4):314–8. 10.1097/COH.0b013e32832aa902PubMedCrossRef
18.
Haley N, Roy E, Leclerc P, Boudreau J-F, Boivin J-F: HIV risk profile of male street youth involved in survival sex. Sex Transm Infect 2004, 80:526–30. 10.1136/sti.2004.010728PubMedCentralPubMedCrossRef
19.
McGowan JP1, Shah SS, Ganea CE, Blum S, Ernst JA, Irwin KL, Olivo N, Weidle PJ: Risk behavior for transmission of human immunodeficiency virus (HIV) among HIV-seropositive individuals in an urban setting. Clin Infect Dis 2004,1(38(1)):122–7. Epub 2003 Dec 4CrossRef
20.
DeSimone J: Needle exchange programs and drug injection behavior. J Policy Anal Manage 2005, 24:3.CrossRef
21.
Ksobiech K: A meta-analysis of needle sharing, lending, and borrowing behaviors of needle exchange program attenders. AIDS Educ Prev 2003, 15:3.CrossRef
22.
Tempalski B, Florn PL, Friedman SR, Des Jarlais DC, Friedman JJ, McNight C, Friedman R: Social and political factors predicting the presence of syringe exchange programs in 96 U.S. metropolitan areas. Am J Public Health 2007, 97:3.CrossRef
23.
Kuehn BM: Integrated care needed for patients with HIV, drug abuse and mental illness. JAMA 2008, 300:5.
24.
Kelly JA, Somlai AM, DiFranceisco WJ, Otto-Salaj LL, McAuliffe TL, Hackl KL, Rompa D: Bridging the gap between the science and service of HIV prevention: transferring effective research-based HIV prevention interventions to community AIDS service providers. Am J Public Health 2000,90(7):1082–8.PubMedCentralPubMedCrossRef
25.
26.
Ware NC, Wyatt MA, Haberer J, Baeten JM, Kintu A, Psaros C, Bangsberg D: What’s love got to do with it? Explaining adherence to oral antiretroviral pre-exposure prophylaxis (PrEP) for HIV serodiscordant couples. J Acquir Immune Defic Syndr 2012, 59:5. 10.1097/QAI.0b013e31823ba503CrossRef
27.
Arnold EA, Hazelton P, Lane T, Christopoulos KA, Galindo GR, Steward WT, Morin SF: A qualitative study of provider thoughts on implementing pre-exposure prophylaxis (PrEP) in clinical settings to prevent HIV infection. PLoS One 2012, 7:7. doi:doi:10.1371/journal.pone.0040603
28.
Mimiaga MJ, White JM, Krakower DS, Biello KB, Mayer KH: Suboptimal awareness and comprehension of published preexposure prophylaxis efficacy results among physicians in Massachusetts. AIDS Care Psychol Soc-med Aspect AIDS/HIV 2014,26(6):684–93. doi:doi:10.1080/09540121.2013.845289 10.1080/09540121.2013.845289CrossRef
29.
Viswanathan M, Kraschnewski JL, Nishikawa B, Morgan LC, Honeycutt AA, Thieda P, Jonas DE: Outcomes and costs of community health worker interventions: a systematic review. Med Care 2010,48(9):792. 10.1097/MLR.0b013e3181e35b51PubMedCrossRef
30.
Neuendorf KA: The content analysis guidebook. Thousand Oaks, CA: Sage Publications; 2002.
31.
Hogben M, Liddon N: Disinhibition and risk compensation: scope, definitions, and perspective. Sex Transm Dis 2008,35(12):1009–10. doi:10.1097/OLQ.0b013e31818eb752PubMed
32.
Cassel MM, Halperin DT, Shelton JD, Stanton D: Risk compensation: the Achilles’ heel of innovations in HIV prevention? BMJ 2006, 332:605–7. 10.1136/bmj.332.7541.605CrossRef
33.
Shelton JD, Halperin D, Nantulya V, Potts M, Gayle HD, Holmes KK: Partner reduction is crucial for balanced “ABC” approach to HIV prevention. BMJ 2004, 328:891–3. 10.1136/bmj.328.7444.891PubMedCentralPubMedCrossRef
34.
Spreen WR, Margolis DA, Pottage JCJ: Long-acting injectable antiretrovirals for HIV treatment and prevention. Curr Opin HIV AIDS 2013, 8:565–71. 10.1097/COH.0000000000000002PubMedCentralPubMedCrossRef
35.
Chaiyachati KH, Ogbuoji O, Price M, Suthar AB, Negussie EK, Bärnighausen T: Interventions to improve adherence to antiretroviral therapy: a rapid systematic review. Aids 2014, Suppl 2:S187–204.CrossRef
36.
Croft B, Parish SL: Care integration in the patient protection and affordable care act: implications for behavioral health. Admin Pol Ment Health 2013,40(4):258–63. 10.1007/s10488-012-0405-0CrossRef
Metadata
Title
PrEP in substance abuse treatment: a qualitative study of treatment provider perspectives
Authors
Anya Y Spector
Robert H Remien
Susan Tross
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Substance Abuse Treatment, Prevention, and Policy / Issue 1/2015
Electronic ISSN: 1747-597X
DOI
https://doi.org/10.1186/1747-597X-10-1

Other articles of this Issue 1/2015

Substance Abuse Treatment, Prevention, and Policy 1/2015 Go to the issue

Research

Paths to improving engagement among racial and ethnic minorities in addiction health services

Research

Results of a cluster randomised controlled trial to reduce risky use of alcohol, alcohol-related HIV risks and improve help-seeking behaviour among safety and security employees in the Western Cape, South Africa

Research

Beyond recidivism: changes in health and social service involvement following exposure to drug treatment court

Research

Do cravings predict smoking cessation in smokers calling a national quit line: secondary analyses from a randomised trial for the utility of ‘urges to smoke’ measures

Research

The association of both self-reported and behavioral impulsivity with the annual prevalence of substance use among early adolescents

Research

European laws on compulsory commitment to care of persons suffering from substance use disorders or misuse problems– a comparative review from a human and civil rights perspective